FTYCX
Price
$53.57
Change
+$0.25 (+0.47%)
Updated
Jun 2 closing price
Net Assets
11.18B
NAESX
Price
$141.48
Change
+$1.11 (+0.79%)
Updated
Jun 2 closing price
Net Assets
177.42B
Interact to see
Advertisement

FTYCX vs NAESX

Header iconFTYCX vs NAESX Comparison
Open Charts FTYCX vs NAESXBanner chart's image
FTYCX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
FTYCX vs. NAESX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTYCX is a StrongBuy and NAESX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 177B vs. FTYCX (11.2B). NAESX pays higher dividends than FTYCX: NAESX (1.08) vs FTYCX (0.00). FTYCX was incepted earlier than NAESX: FTYCX (7 years) vs NAESX (66 years). FTYCX (1.64) is less costly to investors than NAESX (0.17). FTYCX is a more actively managed with annual turnover of: 28.00 vs. NAESX (17.00). NAESX has a lower initial minimum investment than FTYCX: NAESX (0) vs FTYCX (1000). NAESX annual gain was more profitable for investors over the last year : 28.95 vs. FTYCX (26.92). FTYCX return over 5 years is better than : 46.53 vs. NAESX (33.38).
FTYCXNAESXFTYCX / NAESX
Total Expense Ratio1.640.17965%
Annual Report Gross Expense Ratio1.640.17965%
Fund Existence7 years66 years-
Gain YTD9.73513.68071%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.2B177B6%
Annual Yield % from dividends0.001.08-
Returns for 1 year26.9228.9593%
Returns for 3 years54.2354.8699%
Returns for 5 years46.5333.38139%
Returns for 10 yearsN/A160.50-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIOTX27.03N/A
N/A
Victory Pioneer Core Equity A
VGLSX12.61N/A
N/A
VALIC Company I Global Strategy
EIHSX12.76N/A
N/A
Eaton Vance Worldwide Health Sci I
FHKFX15.66N/A
N/A
Fidelity Series Emerging Markets
MDOAX12.52N/A
N/A
Morgan Stanley Developing Opportunity A